المنشورات طباعة Rush BK, Kim L, Savinoff S, Watson M, Strom L. Ask the Patient: Goals for Functional seizure treatment. Epilepsy Behav. 2024 Dec; 161:110141 Epub 2024 Nov 13 View PubMed Stucky KJ, Baker LN, Rush BK, Waldron-Perrine B, Dean PM, Tlustos SJ, Barisa M. Training in Neurorehabilitation Psychology: Defining Competencies, Requisite Skill Sets, and a Proposed Developmental Pathway. Arch Phys Med Rehabil. 2024 Mar; 105 (3):604-610 Epub 2023 Aug 30 View PubMed Silverberg ND, Rush BK. Neuropsychological evaluation of functional cognitive disorder: A narrative review. Clin Neuropsychol. 2024 Feb; 38 (2):302-325 Epub 2023 June 27 View PubMed Rutherford HA, Rush BK, Smith A, Sullivan E, Martinez-Rubio C, Toumadj A, Piana R, Cassandro C. Mapping the journey of patients and care partners living with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: developing a framework for improvements in care. Neurodegener Dis Manag. 2024; 14 (5):161-172 Epub 2024 Oct 03 View PubMed Drane DL, Hewitt KC, Price ME, Rush BK, Blackmon K, Okada N, Shade T, Valentin E, Vinson J, Rosen P, Loring DW. Case study of invalid to valid shift in cognitive performance following successful treatment of psychogenic nonepileptic seizure events. J Clin Exp Neuropsychol. 2023 Dec; 45 (10):1024-1038 Epub 2024 Mar 27 View PubMed Prabhakaran D, Day GS, Munipalli B, Rush BK, Pudalov L, Niazi SK, Brennan E, Powers HR, Durvasula R, Athreya A, Blackmon K. Neurophenotypes of COVID-19: Risk factors and recovery outcomes. Brain Behav Immun Health. 2023 Jul; 30:100648 Epub 2023 June 04 View PubMed Rush BK, Tipton PW, Strongosky A, Wszolek ZK. Neuropsychological profile of CSF1R-related leukoencephalopathy. Front Neurol. 2023; 14:1155387 Epub 2023 June 02 View PubMed Tipton PW, Kenney-Jung D, Rush BK, Middlebrooks EH, Nascene D, Singh B, Holtan S, Ayala E, Broderick DF, Lund T, Wszolek ZK. Treatment of CSF1R-Related Leukoencephalopathy: Breaking New Ground. Mov Disord. 2021 Dec; 36 (12):2901-2909 Epub 2021 July 30 View PubMed Buciuc M, Whitwell JL, Kasanuki K, Graff-Radford J, Machulda MM, Duffy JR, Strand EA, Lowe VJ, Graff-Radford NR, Rush BK, Franczak MB, Flanagan ME, Baker MC, Rademakers R, Ross OA, Ghetti BF, Parisi JE, Raghunathan A, Reichard RR, Bigio EH, Dickson DW, Josephs KA. Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype. Ann Neurol. 2021 Mar; 89 (3):520-533 Epub 2020 Dec 17 View PubMed Hasan TF, Haranhalli N, Mbabuike N, Akinduro OO, Garcia OG, Rush BK, Pedraza O, Tawk RG. Aneurysmal subarachnoid hemorrhage: A pilot study for using longitudinal cognitive and neuropsychological testing for functional outcomes. Clin Neurol Neurosurg. 2020 Jul; 194:105941 Epub 2020 May 20 View PubMed Woolley SC, Rush BK. Considerations for Clinical Neuropsychological Evaluation in Amyotrophic Lateral Sclerosis. Arch Clin Neuropsychol. 2017 Nov 1; 32 (7):906-916 View PubMed Gendron TF, Daughrity LM, Heckman MG, Diehl NN, Wuu J, Miller TM, Pastor P, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Benatar M, Silani V, Glass JD, Floeter MK, Jeromin A, Boylan KB, Petrucelli L, C9ORF72 Neurofilament Study Group. Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis. Ann Neurol. 2017 Jul; 82 (1):139-146 View PubMed Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang YJ, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O'Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, Tabassian LJ, Lee CW, Yue M, Tong J, Song Y, Castanedes-Casey M, Rousseau L, Phillips V, Dickson DW, Rademakers R, Fryer JD, Rush BK, Pedraza O, Caputo AM, Desaro P, Palmucci C, Robertson A, Heckman MG, Diehl NN, Wiggs E, Tierney M, Braun L, Farren J, Lacomis D, Ladha S, Fournier CN, McCluskey LF, Elman LB, Toledo JB, McBride JD, Tiloca C, Morelli C, Poletti B, Solca F, Prelle A, Wuu J, Jockel-Balsarotti J, Rigo F, Ambrose C, Datta A, Yang W, Raitcheva D, Antognetti G, McCampbell A, Van Swieten JC, Miller BL, Boxer AL, Brown RH, Bowser R, Miller TM, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Traynor BJ, Disney MD, Benatar M, Silani V, Glass JD, Floeter MK, Rothstein JD, Boylan KB, Petrucelli L. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Sci Transl Med. 2017 Mar 29; 9 (383) View PubMed Sachs BC, Rush BK, Pedraza O. Validity and reliability of the NAB Naming Test. Clin Neuropsychol. 2016 May; 30 (4):629-38 Epub 2016 Mar 30 View PubMed Gendron TF, van Blitterswijk M, Bieniek KF, Daughrity LM, Jiang J, Rush BK, Pedraza O, Lucas JA, Murray ME, Desaro P, Robertson A, Overstreet K, Thomas CS, Crook JE, Castanedes-Casey M, Rousseau L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Rademakers R, Lagier-Tourenne C, Edbauer D, Cleveland DW, Dickson DW, Petrucelli L, Boylan KB. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol. 2015 Oct; 130 (4):559-73 Epub 2015 Sept 08 View PubMed Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012 Mar; 135 (Pt 3):765-83 View PubMed Pedraza O, Sachs BC, Ferman TJ, Rush BK, Lucas JA. Difficulty and discrimination parameters of Boston naming test items in a consecutive clinical series. Arch Clin Neuropsychol. 2011 Aug; 26 (5):434-44 Epub 2011 May 18 View PubMed Rush BK, McNeil RB, Gamble DM, Luke SH, Richie AN, Albers CS, Brown RD, Brott TG, Meschia JF. Behavioral symptoms in long-term survivors of ischemic stroke. J Stroke Cerebrovasc Dis. 2010 Jul-Aug; 19(4):326-32. View PubMed Malec JF, Testa JA, Rush BK, Brown AW, Moessner AM. Self-assessment of impairment, impaired self-awareness, and depression after traumatic brain injury. J Head Trauma Rehabil. 2007 May-Jun; 22(3):156-66. View PubMed Rush BK, Barch DM, Braver TS. Accounting for cognitive aging: context processing, inhibition or processing speed? Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006 Sep-Dec; 13 (3-4):588-610 View PubMed Rush BK, Malec JF, Brown AW, Moessner AM. Personality and functional outcome following traumatic brain injury. Rehabil Psychol. 2006 Aug; 51(3):257-64. Braver TS, Satpute AB, Rush BK, Racine CA, Barch DM. Context processing and context maintenance in healthy aging and early stage dementia of the Alzheimer's type. Psychol Aging. 2005 Mar; 20(1):33-46. View PubMed Rush BK, Malec JF, Moessner AM, Brown AW. Pre-injury personality and the prediction of early neurobehavioral symptoms following mild traumatic brain injury. Rehabil Psychol. 2004; 49:275-81. Braver TS, Barch DM, Keys BA, Carter CS, Cohen JD, Kaye JA, Janowsky JS, Taylor SF, Yesavage JA, Mumenthaler MS, Jagust WJ, Reed BR. Context processing in older adults: evidence for a theory relating cognitive control to neurobiology in healthy aging. J Exp Psychol Gen. 2001 Dec; 130(4):746-63. View PubMed Christ SE, White DA, Mandernach T, Keys BA. Inhibitory control across the life span. Dev Psychol. 2001; 20:653-69. Keys BA, White DA. Exploring the relationship between age, executive abilities, and psychomotor speed. J Int Neuropsychol Soc. 2000 Jan; 6(1):76-82. View PubMed Bartok JA, Wilson CS, Giordani B, Keys BA, Persad CC, Foster NL, Berent S. Varying patterns of verbal recall, recognition, and response bias with progression of Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 1997; 4:266-72. PST-20222648 الصفحة الرئيسية المنشورات